|

Humanized CD19 CAR-T cells Clinical Trials

1 actively recruiting trial

Also known as: Humanized CD19 CAR-T cells injection

Pipeline

Early 1: 1

Top Sponsors

  • Zhejiang University1

Indications

  • Non-hodgkin Lymphoma,B Cell1
  • Acute Lymphoblastic Leukemia1
  • Cancer1

Other1 trial

A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.